Harnessing crispr-cas to combat covid-19: From diagnostics to therapeutics
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global threat with an ever-increasing death toll even after a year on. Hence, the rapid identification of infected individuals with diagnostic tests continues to be crucial in t...
| Published in: | Life |
|---|---|
| Main Author: | |
| Format: | Review |
| Language: | English |
| Published: |
MDPI
2021
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118994920&doi=10.3390%2flife11111210&partnerID=40&md5=9666d187313d27088d6813d2441a934a |